S&P/ASX 200 Index (ASX: XJO) shares are 0.6% higher at 8.875.9 points on Thursday.
This week, brokers have reduced their ratings on several ASX 200 shares.
Let's take a look.
Image source: Getty Images
Cochlear Ltd (ASX: COH)
The Cochlear share price is $110.20, down 1.7% today and down 65% over 12 months.
RBC Capital downgraded the ASX 200 healthcare share to a hold rating.
The broker reduced its 12-month price target from $125 to $117.
This implies a potential 6% upside ahead.
AMP Ltd (ASX: AMP)
The AMP share price is $2.15, up 0.7% today and up 29% over 12 months.
Jarden downgraded AMP shares to a hold rating, but increased its price target from $1.65 to $2.
This suggests a potential 7% downside ahead for the ASX 200 financial share.
Wesfarmers Ltd (ASX: WES)
The Wesfarmers share price is $88.76, down 1.3% today and up 6.8% over 12 months.
Morgan Stanley downgraded the ASX 200 consumer discretionary share to a sell rating today.
The broker lifted its 12-month price target slightly from $78.70 to $79.
This implies a potential 11% downside ahead.
Woolworths Group Ltd (ASX: WOW)
The Woolworths share price is $38.93, down 0.9% today and up 25% over 12 months.
JP Morgan downgraded the ASX 200 consumer staples share to a hold rating.
The broker raised its 12-month price target from $37 to $39.50.
This indicates a potential capital gain of just 1% over the next year.
Coles Group Ltd (ASX: COL)
The Coles share price is $23.50, up 0.4% today and up 16% over 12 months.
JP Morgan downgraded Coles shares to a hold rating with a $23.50 target.
This suggests the stock is fully valued at today's price.
Flight Centre Travel Group Ltd (ASX: FLT)
The Flight Centre share price is $11.80, down 0.3% today and down 12% over 12 months.
Citi downgraded the ASX 200 travel share to a hold rating with a $13.20 target.
This suggests a potential 12% upside ahead.
Centuria Industrial REIT (ASX: CIP)
The Centuria Industrial REIT share price is $3.01, up 1.9% today and down 4% over 12 months.
Bell Potter downgraded the real estate investment trust (REIT) to a hold rating with a $3.25 target yesterday.
This suggests potential capital growth of 8% over the next year.
Telix Pharmaceuticals Ltd (ASX: TLX)
The Telix Pharmaceuticals share price is $14.95, up 0.6% today and down 30% over 12 months.
RBC Capital downgraded the ASX 200 tech share to a hold rating with an $18 target.
This still implies a healthy potential 20% upside ahead.
